BioMarin to buy Prosensa in $840 million deal 11/24/2014 majac Your Health Matters (Reuters) – BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million including milestone payments, aiming to add to its portfolio of drugs to treat rare diseases. Go to Source Share on FacebookTweetFollow usSave